Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cycles
dc.citation.epage | 365 | en_US |
dc.citation.issueNumber | 5 | en_US |
dc.citation.spage | 361 | en_US |
dc.citation.volumeNumber | 32 | en_US |
dc.contributor.author | Demir, B. | en_US |
dc.contributor.author | Kahyaoglu, I. | en_US |
dc.contributor.author | Guvenir, A. | en_US |
dc.contributor.author | Yerebasmaz, N. | en_US |
dc.contributor.author | Altinbas, S. | en_US |
dc.contributor.author | Dilbaz, B. | en_US |
dc.contributor.author | Dilbaz, S. | en_US |
dc.contributor.author | Mollamahmutoglu, L. | en_US |
dc.date.accessioned | 2018-04-12T10:45:14Z | |
dc.date.available | 2018-04-12T10:45:14Z | |
dc.date.issued | 2016 | en_US |
dc.department | Department of Computer Engineering | en_US |
dc.description.abstract | Objective: The aim of the presented study is to investigate the impact of progesterone change in the late follicular phase on the pregnancy rates of both agonist and antagonist protocols in normoresponders.Study design: A total of 201 normoresponder patients, who underwent embryo transfer were consecutively selected. 118 patients were stimulated using a long luteal GnRH agonist protocol and 83 using a flexible antagonist protocol. The level of change in late follicular phase progesterone was calculated according to the progesterone levels on the hCG day and pre-hCG day (1 or 2 days prior to hCG day) measurement.Results: Clinical pregnancy rates were comparable between long luteal and antagonist group (35.6 and 41%, respectively). The incidence of progesterone elevation on the hCG day was 11% in long luteal and 18% in antagonist group (p = 0.16). In pregnant cycles, p levels both on the hCG day and pre-hCG day measurement were significantly higher in antagonist than agonist cycles (p = 0.029, p = 0.038, respectively). The change of p level was statistically significant in non-pregnant cycles both for the agonist (-0.17 ± 0.07; 95% CI: -0.29 to -0.37) and antagonist groups (-0.18 ± 0.07; 95%CI: -0.31 to -0.04).Conclusions: Late follicular phase progesterone levels were stable during the cycles of pregnant patients irrespective of the protocols and were shown to be higher in pregnant patients in antagonist cycles when compared to agonist cycles. | en_US |
dc.description.provenance | Made available in DSpace on 2018-04-12T10:45:14Z (GMT). No. of bitstreams: 1 bilkent-research-paper.pdf: 179475 bytes, checksum: ea0bedeb05ac9ccfb983c327e155f0c2 (MD5) Previous issue date: 2016 | en |
dc.identifier.doi | 10.3109/09513590.2015.1121226 | en_US |
dc.identifier.eissn | 1473-0766 | en_US |
dc.identifier.issn | 0951-3590 | en_US |
dc.identifier.uri | http://hdl.handle.net/11693/36587 | en_US |
dc.language.iso | English | en_US |
dc.publisher | Taylor & Francis | en_US |
dc.relation.isversionof | http://dx.doi.org/10.3109/09513590.2015.1121226 | en_US |
dc.source.title | Gynecological Endocrinology | en_US |
dc.subject | GnRH antagonist | en_US |
dc.subject | In-vitro fertilization | en_US |
dc.subject | Intracytoplasmic sperm injection | en_US |
dc.subject | Progesterone | en_US |
dc.subject | Chorionic gonadotropin | en_US |
dc.subject | Estradiol | en_US |
dc.subject | Follitropin | en_US |
dc.subject | Gonadorelin agonist | en_US |
dc.subject | Luteinizing hormone | en_US |
dc.subject | Progesterone | en_US |
dc.subject | Cetrorelix | en_US |
dc.subject | Follitropin | en_US |
dc.subject | Ganirelix | en_US |
dc.subject | Gonadorelin | en_US |
dc.subject | Hormone antagonist | en_US |
dc.subject | Leuprorelin | en_US |
dc.subject | Luteinizing hormone | en_US |
dc.subject | Progesterone | en_US |
dc.subject | Adult | en_US |
dc.subject | Controlled study | en_US |
dc.subject | Embryo transfer | en_US |
dc.subject | Female | en_US |
dc.subject | Fertilization in vitro | en_US |
dc.subject | Follicular phase | en_US |
dc.subject | Human | en_US |
dc.subject | Incidence | en_US |
dc.subject | Intracytoplasmic sperm injection | en_US |
dc.subject | Luteal phase | en_US |
dc.subject | Major clinical study | en_US |
dc.subject | Pregnancy rate | en_US |
dc.subject | Priority journal | en_US |
dc.subject | Progesterone blood level | en_US |
dc.subject | Analogs and derivatives | en_US |
dc.subject | Antagonists and inhibitors | en_US |
dc.subject | Blood | en_US |
dc.subject | Case control study | en_US |
dc.subject | Follicular phase | en_US |
dc.subject | Ovulation induction | en_US |
dc.subject | Pregnancy | en_US |
dc.subject | Procedures | en_US |
dc.subject | Case-control studies | en_US |
dc.subject | Embryo transfer | en_US |
dc.subject | Female | en_US |
dc.subject | Follicle stimulating hormone | en_US |
dc.subject | Follicular phase | en_US |
dc.subject | Gonadotropin-releasing hormone | en_US |
dc.subject | Hormone antagonists | en_US |
dc.subject | Humans | en_US |
dc.subject | Leuprolide | en_US |
dc.subject | Luteinizing Hormone | en_US |
dc.subject | Ovulation Induction | en_US |
dc.subject | Pregnancy | en_US |
dc.subject | Pregnancy Rate | en_US |
dc.subject | Progesterone | en_US |
dc.subject | Sperm Injections | en_US |
dc.subject | Intracytoplasmic | en_US |
dc.title | Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders: a case-controlled study in ICSI cycles | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Progesterone change in the late follicular phase affects pregnancy rates both agonist and antagonist protocols in normoresponders a case-controlled study in ICSI cycles.pdf
- Size:
- 592.38 KB
- Format:
- Adobe Portable Document Format
- Description:
- Full printable version